Search PubMed⌕ Search

Biomedical subjects

N Yamazaki

Publications and source records attributed to N Yamazaki.

At least 307 records · Page 17Linked to original sources
PubMed1980

[Plasma catecholamine content in hypertensive subjects and spontaneously hypertensive rats using radioenzymatic assay (author's transl)].

The present experiments were undertaken to determine the plasma catecholamine content in normotensive, slightly hypertensive humans and spontaneously hypertensive rats using radioenzymatic assay. In addition, attempts were made to compare radioenzymatic assay with a fluorometric technique, using high performance liquid chromatography with respect to human plasma catecholamine content. Human plasma catecholamine content in normotensive subjects at rest was 250 +/- 61 pg/ml (mean +/- S.E.) for norepinephrine and 37 +/- 22 for epinephrine. Immediately after treadmill exercise, human plasma norepinephrine content significantly increased. In 14 patients with mild essential hypertension, plasma norepinephrine was 460 +2- 128 pg/ml with the subject in a supine position and 1030 +/- 151 in the case of treadmill exercise. Thus, there was a statistically significant difference. With regard to plasma catecholamine content in spontaneously hypertensive rats, the norepinephrine content was 816 pg/ml, epinephrine was 209 pg/ml and dopamine was 505 pg/ml, on an average. After comparing this method with the fluorometric technique using high performance liquid chromatography, we confirmed that the former requires much smaller sizes of samples and has much the same sensitivity as the latter.

Adult↗
PubMed1979

[Changes of plasma levels of TRH and its target hormones by two hour constant intravenous infusion of TRH tartrate in man (author's transl)].

Constant iv infusion of TRH tartrate for 2 hours was administered to normal men in a dosage of 0.5 (n=4), 1.0 (n=2) and 2 (n=4) mg/120 minutes. Measurements at every 15 minutes were performed for plasma levels of TRH, TSH, Thyroxine (T4) and Triiodothyronine (T3) by radioimmunoassay. Plasma levels of TRH increased promptly and stayed at the same levels until the end of the infusion. The Mean Clearance Rate (MRC), Half-life and Volume of Distribution of TRH were respectively, 4.62 +/- 0.53 L/min. (M +/- SE), 17.8 +/- 3.8 minutes and 112 +/- 15 L in the 0.5 mg administered group and 6.38 +/- 2.50 L/min., 9.0 +/- 1.4 minutes and 82 +/- 30 L in the 2 mg administered group. Plasma levels of TRH increased in two phases, and increments of plasma TSH were dose dependable to the dosage of TRH. Plasma levels of T4 increased gradually in the course of TRH infusion and stayed at high levels even in the withdrawal phase of TRH. Plasma levels of T3 increased markedly during and after the TRH infusion in the 0.5 mg administered group, while increments of plasma T3 were minute in the 2 mg administered group. From the above data, it is suggested that the amount of TRH production in man, which is much more than has previously been reported, may indicate the existence of an extrahypothalamic synthesis of TRH in man.

Adult↗
PubMed1979

Concentration of myocardial cyclic AMP and ventricular fibrillation induced by aminophylline.

The concentration of myocardial cyclic AMP was measured in 9 dogs by radioimmunoassay after the administration of aminophylline. Fourteen dogs served as control. The concentration of cyclic AMP in the left ventricle was the highest and the lowest value was obtained in the right atrium in the control dogs. Ventricular fibrillations were induced immediately after the injection of 30 mg/Kg aminophylline in 3 dogs out of 9. The concentration of the left ventricular cyclic AMP in 6 dogs which tolerated aminophylline was significantly elevated compared with that of the control dogs (p less than 0.05). The left ventricular cyclic AMP in 3 dogs with ventricular fibrillation was significantly higher compared with that in the aminophylline tolerated dogs with non-fibrillating hearts (p less than 0.01). These results showed that the concentration of cyclic AMP was elevated in the fibrillating heart.

Aminophylline↗
PubMed1977

Dopamine-beta-hydroxylase activity after acute myocardial infarction.

Serum dopamine-beta-hydroxylase (DBH) activities of 74 apparently healthy adults were not distributed normally, but skewed to the right. There were at least 2 subgroups in the distribution of DBH activity. Accordingly, 27 serial serum DBH activities following acute myocardial infarction were divided into 2 subgroups according to their activities on the 10th day or/and thereafter. The DBH activity was significantly elevated on the 1st day with average of 157% of the 10th day (p less than 0.015) in high DBH subgroup and also significantly elevated on the 1st and 2nd day with the average of 182% and 155%, respectively, of the 10th day (p=0.025 and p less than 0.05) in low DBH subgroup. There was no significant difference between the DBH activity of patients with anterior myocardial infarction and that of patients with inferior myocardial infarction. No significant correlation between the DBH activity and the coronary prognostic index was found. The observed elevation of the DBH activity on the 1st and 2nd day suggests an augmentation in the sympathetic nervous activity after acute myocardial infarction.

Acute Disease↗
PubMed1976

Serum dopamine beta-hydroxylase in cardiovascular diseases.

Dopamine-beta-hydroxylase (DBH), the enzyme responsible for the biosynthesis of norepinephrine from dopamine was assayed in the blood serum of 23 normal adults, 16 patients with congestive heart failure, 19 patients with asymptomatic ischemic heart disease, 4 patients with angina pectoris at rest, 15 patients with essential hypertension, 8 patients with essential hypotension, 5 patients with neurocirculatory asthenia, and 9 normal adults before and after the exercise test. The serum DBH activity varied within a wide range in the control population. The DBH activity increased about 16% after the exercise stress. A tendency to increase DBH activity was shown in the patients with congestive heart failure. There was no significant difference between asymptomatic ischemic heart disease, essential hypertension and normal controls. A lower value was observed in the patients of angina pectoris at rest, while a higher DBH activity was demonstrated in the patients with essential hypotension. There was no significant difference between the neurocirculatory asthenia group and the normal control group.

Adult↗